Clinical Trials Browser

Phase 2 × Thymoma × NVP-BKM120 × Clear all

NCT02220855 2022-04-11

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

Phase 2 Completed

14 enrolled 14 charts

Thymoma